Ametumumab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ametumumab, covering 2023-02-01 to 2023-02-01. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Ametumumab in Combination With Anti-PD-1 Monoclonal Antibody and FOLFIRI in Patients With RAS Wild-type Advanced Colorectal Cancer [Phase 2]